Department of Haematology, Indus Hospital and Health Network, Karachi, Pakistan.
Research Centre, Indus Hospital and Health Network, Karachi, Pakistan.
J Ayub Med Coll Abbottabad. 2024 Apr-Jun;36(2):454-458. doi: 10.555/JAMC-02-12731.
Chediak Higashi syndrome (CHS), a rare form of autosomal recessive disorder has been reported globally in less than 500 cases over the past two decades. It clinically manifests as repeated episodes of infection, haemorrhagic sequelae, partial albinism, photosensitivity and late neurological signs (neuropathy, cognitive impairment etc). The pathognomonic morphological finding is the presence of abnormally large intra-cytoplasmic granules, particularly in leucocytes. Almost 85% of CHS cases advance into an accelerated phase, characterized by cytopenias and hemophagocytosis, leading to multi-organ failure.
The child in the present case had consanguinity and a positive family history of recurrent infections. She had repeated episodes of bacterial infections. She also had a history of photosensitivity. CBC reported cytopenias. Peripheral smear showed neutrophils with characteristic large sized abnormal intra-cytoplasmic granules. Bone marrow biopsy was performed which also showed similar granules in leucocytes along with hemophagocytosis. Other clinical and biochemical markers also pointed towards hemophagocytic lymphohistiocytosis (HLH), thus patient was diagnosed as CHS in an accelerated phase. She received eight doses of chemotherapy but eventually expired.
The definitive treatment is hematopoietic stem cell transplantation which improves the hematological and immune aspects of CHS but not the neurological. Steps should be taken for early diagnosis and to prevent advancement into the accelerated phase.
Chediak-Higashi 综合征(CHS)是一种罕见的常染色体隐性遗传疾病,在过去二十年中,全球报告的病例少于 500 例。它在临床上表现为反复感染、出血后遗症、部分白化病、光敏性和晚期神经症状(神经病、认知障碍等)。特征性的形态学发现是存在异常大的细胞内颗粒,特别是在白细胞中。几乎 85%的 CHS 病例会进入加速期,其特征是细胞减少症和噬血细胞现象,导致多器官衰竭。
本病例中的患儿有血缘关系和反复感染的阳性家族史。她反复发生细菌感染。她也有光敏性病史。CBC 报告有细胞减少症。外周涂片显示中性粒细胞有特征性的大尺寸异常细胞内颗粒。骨髓活检也显示白细胞中有类似的颗粒,同时伴有噬血细胞现象。其他临床和生化标志物也指向噬血细胞性淋巴组织细胞增生症(HLH),因此患者被诊断为加速期的 CHS。她接受了八轮化疗,但最终死亡。
明确的治疗方法是造血干细胞移植,这可以改善 CHS 的血液学和免疫学方面,但不能改善神经学方面。应采取措施尽早诊断,并防止进入加速期。